Skip to content
Clinical Trials – home

University Multiprofile Hospital For Active Treatment Sofiamed OOD

Verifiedinfo

Bulgaria Bulevard D-R G.m.dimitrov 16, 1797 Sofia, Bulgaria

  • 14 trials recruiting
  • Non-small cell lung cancer · Obesity · Immune thrombocytopenia
  • Adults and children

About Specializations

University Multiprofile Hospital For Active Treatment Sofiamed OOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Non-small cell lung cancer, Obesity, Immune thrombocytopenia, Chronic hepatitis B, and other specialisations. This site conducts important research.

Main research areas of the site

Hepatology

The medical center is at the forefront of hepatology research, focusing on innovative treatments for liver diseases. The center's work on Non-Alcoholic Steatohepatitis (NASH) is particularly noteworthy, as it explores the efficacy and safety of novel therapeutic agents.

  • Non-Alcoholic Steatohepatitis (NASH)
  • Chronic Hepatitis B

Through its research, the center aims to improve patient outcomes and advance the understanding of liver disease pathophysiology.

Oncology

Specializing in oncology, the center conducts cutting-edge research on various cancers, including lung cancer and urothelial cancer. The focus is on developing and assessing new treatment combinations to enhance survival rates and quality of life for patients.

  • Non-Small Cell Lung Cancer (NSCLC)
  • Urothelial Cancer
  • Prostate Cancer

The center's research contributes significantly to the global fight against cancer, offering hope through innovative therapies.

Immunology

In the field of immunology, the center is pioneering research on immune-related conditions, with a particular emphasis on Systemic Lupus Erythematosus (SLE) and chronic infections. The goal is to develop therapies that modulate the immune system effectively.

  • Systemic Lupus Erythematosus (SLE)
  • Chronic Lymphocytic Leukemia

By advancing immunological research, the center aims to provide new treatment avenues for patients with complex immune disorders.

Endocrinology

The center's endocrinology research is dedicated to addressing metabolic disorders, with a strong focus on Type 2 Diabetes and hypertriglyceridemia. The research aims to enhance therapeutic strategies and improve metabolic health.

  • Type 2 Diabetes
  • Severe Hypertriglyceridemia

Through its work, the center seeks to transform the management of metabolic diseases, offering patients better control and outcomes.

Infectious Diseases

Focusing on infectious diseases, the center is involved in groundbreaking research on viral infections, including Respiratory Syncytial Virus (RSV) and Hepatitis B. The aim is to develop effective treatments and preventive strategies.

  • Respiratory Syncytial Virus (RSV)
  • Chronic Hepatitis B

The center's research efforts are crucial in combating infectious diseases, contributing to global health improvements.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Bulevard D-R G.m.dimitrov 161797 SofiaBulgaria
Recruiting now
14 trials
Conditions studied
46
Partner status
Verified

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

46 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH

Hepatitis D+1

Recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:GS-4321
  • Sponsor:Gilead Sciences Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Takeda Development Center Americas Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Daiichi Sankyo Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Ascentage Pharma Group Inc.
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Maia Biotechnology Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.